-
Social Networks Unpacked – Six Charts That Explain the Rise of Facebook, Twitter, and Instagram
July 07, 2015 | by James Wang, ARK Analyst | DigitalThe three most popular consumer social networks, Facebook , Twitter , and Instagram, have grown from scrappy upstarts to some of the most powerful communication platforms on earth. Despite the similarities of these platforms, users, celebrities, and companies are embracing them in different ways. To understand how they are evolving and performing, ARK researched engagement […]
Biosimilars vs Generics: History Does Not Repeat, It Rhymes
May 18, 2015 | by Erik Tvetenstrand, ARK Analyst | HealthHealthcare investors likely remember the devastating impact of generic drugs on drug prices in the late 1980s. While traditional firms struggled, many successful biotechnology companies took root during this turbulent period. Focusing on the growing field of biologic medicine, many biotech firms were acquired by pharmaceutical companies looking to lower research and development costs, while […]
Immunotherapy: Unleashing the Immune System to Decimate Cancer
April 10, 2015 | by James Bannon, ARK Analyst | HealthFor more than a century, surgery and poison have been the antidotes to cancer. When tumors are discovered, doctors decide whether or not to remove them surgically. With or without surgery, doctors typically prescribe chemotherapy in an attempt to eradicate the disease chemically. Immunotherapy is the most heralded cancer treatment of the last 20 years, offering […]
Curing Diabetes with Stem Cells
December 02, 2014 | by James Bannon, ARK Analyst | HealthNew research out of Harvard University’s Stem Cell Institute may have cracked the code to curing diabetes. In a break-through study, scientists were able to turn human embryonic stem cells into fully mature insulin-producing beta cells and implant them into living tissue. While currently only in animals, these studies, if successful in humans, could point […]